Rhodes Group & BCBSNM team up to improve patient outcome in New Mexico
Category: #health  By Nikita Chaurasia  Date: 2019-08-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

Rhodes Group & BCBSNM team up to improve patient outcome in New Mexico
  • The collaboration aims to enhance patient outcomes within the New Mexico Centennial Care.
  • BCBSNM is currently holds the accolade of being the foremost performer in Postpartum and Prenatal care.

Rhodes Group (Rhodes), a Albuquerque-based TriCore Reference Laboratories subsidiary, and Blue Cross and Blue Shield of New Mexico (BCBSNM) are reportedly working in partnership to further enhance patient results within the New Mexico Centennial Care.

Rhode Group’s novel Clinical Analytics product implements copyrighted and innovative algorithms to examine TriCore’s clinical pathology information to produce close to real-time, and actionable insights for health conditions like hepatitis C, pregnancy, and diabetes.

Rhodes Group focuses on making software for enhancing laboratory operations. The company’s new software tool; Clinical Analytics, allows laboratories to support their customers with targeted intervention and population health initiatives.

The insights provided by Clinical Analytics help BCBSNM in risk stratifying its Centennial Care demographic, thus recognizing the members who should be taken care of or could be at risk because of comorbidity.

CEO of Rhodes Group, Steve Ayer stated that laboratory outcomes work crucially to determine patient needs and in clinical decisions. The company has innovatively revolutionized single test output to present data that increases BCBSNM’s ability to cater to the requirements of its Centennial Care population. 

TriCore’s Chief Executive Officer and Chief Medical Officer, Dr. Michael Crossey stated that BCBSNM have been a great partner because of the company’s willingness to try something unique, educate Rhodes Group on member needs, and truly cause healthcare silos’ breakdown.

Chief Medical Officer of BCBSNM, Dr. Eugene Sun stated that the product has immensely helped the company to understand member necessities and work more efficiently towards integrating patients into patient care.

BCBSNM and Rhodes Group have worked as partners for over a year to make sure that their algorithms created actionable date for the commencement of the care coordination efforts.

BCBSNM is presently the top performer in Postpartum and Prenatal care as stated by the New Mexico Human Services Department’s Healthcare Effectiveness Data and Information Set Report.

Source Credits: https://www.globenewswire.com/news-release/2019/08/01/1896119/0/en/Rhodes-Group-and-Blue-Cross-and-Blue-Shield-of-New-Mexico-are-working-together-to-produce-better-patient-outcomes-within-New-Mexico-Centennial-Care.html

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

FDA approves AstraZeneca’s Farxiga for treating type 2 diabetes
FDA approves AstraZeneca’s Farxiga for treating type 2 diabetes
By Nikita Chaurasia

Type-2 diabetes is classified as a chronic condition that impacts the body’s way of processing blood sugar or glucose. Currently, the condition can be regulated using exercise, diet, insulin therapy and medication. However, pharma companies are...

Herantis Pharma releases update on timeline of its ongoing CDNF trial
Herantis Pharma releases update on timeline of its ongoing CDNF trial
By Nikita Chaurasia

Parkinson's disease (PD) is an incurable, progressive neurodegenerative disease which is caused by the death of dopaminergic neurons in the midbrain. With medication, motor symptoms can be treated but it is impossible to prevent the progression o...

Japan’s SoftBank amid plans to invest in venture capital funds
Japan’s SoftBank amid plans to invest in venture capital funds
By Nikita Chaurasia

The conglomerate plans to mark its presence in Latin America by investing in venture capital funds, with a strategy to deploy nearly $500 million in five to 10 funds. SoftBank Group Corp., a multinational conglomerate based out of Tokyo, reportedly ...